Market Research Logo

Pakistan Pharmaceuticals and Healthcare Report Q4 2017

Pakistan Pharmaceuticals and Healthcare Report Q4 2017

BMI View: In developing markets such as Pakistan, multinational drugmakers will continue to implementprogrammes - alongside governmental bodies - to help improve access to medicines against chronicdiseases. The unmet need for non-communicable disease treatments among low-income patients will createopportunities to provide affordable medicines.

Headline Expenditure Projections

Pharmaceuticals: PKR275.8bn (USD2.6bn) in 2016 to PRK301.2bn (USD2.9bn) 2017; +9.2% in localcurrency terms and +9.3% in US dollar terms. Forecast virtually unchanged from las quarter.

Healthcare: PKR805.7bn (USD7.7bn) in 2016 to PKR878.1bn (USD8.4bn) in 2017; +9.0% in localcurrency terms and +9.0% in US dollar terms. Forecast virtually unchanged from last quarter.

Risk/Reward IndexPakistan's pharmaceutical market will remain a low priority for innovative drugmakers. Downward pricepressures on pharmaceuticals, coupled with uncertainty surrounding the country's policy direction, impingeon potential commercial opportunities. Moreover, patent protection in the country is poor, dissuadingmultinational drugmakers from launching new innovative treatments in the country. This is reflected in thecountry's score of 37.2 out of 100 in BMI's Innovative Pharmaceuticals Risk/Reward Index.


BMI Industry View
Table: Headline Pharmaceuticals & Healthcare Forecasts (Pakistan 2015-2021)
SWOT
Industry Forecast
Pharmaceutical Market Forecast
Table: Pharmaceutical Sales, Historical Data And Forecasts (Pakistan 2013-2021)
Healthcare Market Forecast
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Pakistan 2013-2021)
Table: Government Healt Expenditure Trends, Historical Data And Forecasts (Pakistan 2013-2021)
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Pakistan 2013-2021)
Prescription Drug Market Forecast
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Pakistan 2013-2021)
Patented Drug Market Forecast
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Pakistan 2013-2021)
Generic Drug Market Forecast
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Pakistan 2013-2021)
OTC Medicine Market Forecast
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Pakistan 2013-2021)
Pharmaceutical Trade Forecast
Table: Pharmaceutical Trade Data And Forecasts (Pakistan 2015-2021)
Table: Pharmaceutical Trade Data And Forecasts local currency (Pakistan 2015-2021)
Industry Risk/Reward Index
Asia Pacific Pharmaceuticals: Diverse Opportunities And Inherent Risks
Pakistan - Risk/Reward Index
Rewards
Risks
Regulatory Review
Intellectual Property Issues
Pricing Regime
Reimbursement Regime
Market Overview
Healthcare Sector
Table: Healthcare Resources (Pakistan 2011-2016)
Table: Healthcare Personnel (Pakistan 2011-2016)
Table: Healthcare Activity (Pakistan 2011-2016)
Research & Development
Clinical Trials
Epidemiology
Table: Estimated Number Of New Cases Of Cancer In Pakistan
Competitive Landscape
Research-Based Industry
Table: Multinational Market Activity
Generic Drugmakers
Table: PPMA As Of 2015
Pharmaceutical Distribution
Company Profile
Abbott Laboratories
Efroze Chemical Industries
Ferozsons Laboratories
Getz Pharma
GlaxoSmithKline
Hilton Pharma
Novartis
Pfizer
Sanofi-Aventis
Searle Pakistan Limited
Demographic Forecast
Table: Population Headline Indicators (Pakistan 1990-2025)
Table: Key Population Ratios (Pakistan 1990-2025)
Table: Urban/Rural Population & Life Expectancy (Pakistan 1990-2025)
Table: Population By Age Group (Pakistan 1990-2025)
Table: Population By Age Group % (Pakistan 1990-2025)
Glossary
Methodology
Pharmaceutical Expenditure Forecast Model
Healthcare Expenditure Forecast Model
Notes On Methodology
Risk/Reward Index Methodology
Table: Indicators - Rationale And Sources

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report